Tag: T790M

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to T790M

China Osimertinib Market Report 2021-2025: Originally TAGRISSO Developed by AstraZeneca

Added to Collection on: 2021-06-03 08:26:15

Tags for this article:

Lung cancer
Health sciences
Organic compounds
Chemical compounds
Osimertinib
T790M
Epidermal growth factor receptor
Non-small-cell lung carcinoma
AstraZeneca
Economy of China
China
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing ...

Added to Collection on: 2021-06-30 10:52:30

Tags for this article:

Tyrosine kinase inhibitors
Tyrosine kinase receptors
Lung cancer
T790M
Protein kinase inhibitor
Pharmaceutical industry in China
Epidermal growth factor receptor
Health
Branches of biology
ArriVent Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
Dizal Announces Pre-clinical and Clinical Results of Sunvozertinib (DZD9008) Published in ...

Added to Collection on: 2022-05-06 14:13:57

Tags for this article:

Lung cancer
Chemical compounds
Organic compounds
Cancer
Epidermal growth factor receptor
T790M
Non-small-cell lung carcinoma
Mobocertinib
Gefitinib

Click the tags to see associated articles and topics

View Article Details
Baili, AstraZeneca partner for Phase IIa lung cancer trial of antibody plus Tagrisso

Added to Collection on: 2022-05-16 11:38:08

Tags for this article:

Lung cancer
Organic compounds
Chemical compounds
Cancer
Epidermal growth factor receptor
Osimertinib
Non-small-cell lung carcinoma
T790M
Gefitinib
Si
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Tagrisso gets approval in Japan for early-stage lung cancer subtype

Added to Collection on: 2022-08-25 08:41:56

Tags for this article:

Lung cancer
Organic compounds
Chemical compounds
Cancer
T790M
Osimertinib
Non-small-cell lung carcinoma
Epidermal growth factor receptor
AstraZeneca
Targeted therapy of lung cancer

Click the tags to see associated articles and topics

View Article Details
J&J's Rybrevant in Combo with Lazertinib Clears Phase III in NSCLC - BioSpace

Added to Collection on: 2023-09-28 20:03:05

Tags for this article:

Lung cancer
Breakthrough therapy
Tyrosine kinase inhibitors
Ethers
T790M
Non-small-cell lung cancer
Epidermal growth factor receptor
Amivantamab
Bispecific monoclonal antibody
Protein kinase inhibitor
Osimertinib
Draft:Lazertinib
Johnson & Johnson

Click the tags to see associated articles and topics

View Article Details
Cancer biotech ArriVent Biopharma files for a $100 million IPO - Renaissance Capital

Added to Collection on: 2024-01-05 21:48:51

Tags for this article:

Lung cancer
Quinazolines
Oncogenes
Tyrosine kinase receptors
Tyrosine-kinase inhibitor
Antineoplastic drugs
Epidermal growth factor receptor
Non-small-cell lung cancer
Protein kinase inhibitor
Afatinib
T790M

Click the tags to see associated articles and topics

View Article Details
ArriVent's $175M Upsized IPO Builds Momentum on Heels of CG Oncology Offering

Added to Collection on: 2024-01-26 21:21:58

Tags for this article:

Lung cancer
Oncogenes
Tyrosine kinase receptors
T790M
Non-small-cell lung cancer
Epidermal growth factor receptor

Click the tags to see associated articles and topics

View Article Details
Tagrisso Shows Significant Improvement in Progression-Free Survival in EGFRm NSCLC in ...

Added to Collection on: 2024-06-04 22:56:36

Tags for this article:

Lung cancer
Non-small-cell lung cancer
Osimertinib
T790M
Epidermal growth factor receptor
Gefitinib
Protein kinase inhibitor
Small-cell carcinoma
Adenocarcinoma of the lung
AstraZeneca Pharmaceuticals LP

Click the tags to see associated articles and topics

View Article Details
J&J says Rybrevant combo has survival edge over Tagrisso - pharmaphorum

Added to Collection on: 2025-01-08 15:19:53

Tags for this article:

Lung cancer
Orphan drugs
Acrylamides
Ethers
Tyrosine kinase inhibitors
Osimertinib
Amivantamab
Non-small-cell lung cancer
Epidermal growth factor receptor
Bispecific monoclonal antibody
T790M
Gefitinib
Johnson & Johnson
AstraZeneca
Johnson & Johnson's

Click the tags to see associated articles and topics

View Article Details